RxDoctor Payments Data

Cynthia Milstead, NP

Family · Dothan, ALNPI 1033240601

Payments from drug & device makers

$419in general payments, 2019–2025

Across 26 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$82
  • Pfizer$54
  • Lilly USA, LLC$48
  • Merck$45
  • Biohaven Pharmaceutical Holding Company Ltd.$41
  • AbbVie$28
  • plus $121 from 7 others

What the payments were for

  • Food & beverage$419100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$419 in reported general payments places this provider in the 45th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$802
Medicare patients
35
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide134$211,937
JardianceEmpagliflozin105$134,435
TrulicityDulaglutide32$47,195
MounjaroTirzepatide24$43,776
JanuviaSitagliptin Phosphate22$32,119
LinzessLinaclotide26$16,665
EliquisApixaban23$15,210
VascepaIcosapent Ethyl21$7,498
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$7,209
XareltoRivaroxaban11$6,305
Rosuvastatin Calcium308$5,932
Ezetimibe185$4,357
Albuterol Sulfate HfaAlbuterol Sulfate97$2,716
Amlodipine Besylate315$1,988
Megestrol Acetate16$1,904

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$82$211,937134 claims
Boehringer IngelheimJardiance$19$134,435105 claims
Lilly USA, LLCTrulicity, Mounjaro$48$90,97256 claims
MerckJanuvia$45$32,11922 claims
AbbVieLinzess$28$16,66526 claims
PfizerEliquis$54$15,21023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,415 family providers in Alabama.

Other family in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →